187 related articles for article (PubMed ID: 38703562)
1. Effects of antidepressant and antipsychotic medication on peripheral brain-derived neurotrophic factor concentration: Systematic review and meta-analysis.
Merabtine T; Tarhini Z; Preux PM; Christou N; Jost J
Psychiatry Res; 2024 Jul; 337():115946. PubMed ID: 38703562
[TBL] [Abstract][Full Text] [Related]
2. The impact of antidepressant treatment on brain-derived neurotrophic factor level: An evidence-based approach through systematic review and meta-analysis.
Arumugam V; John VS; Augustine N; Jacob T; Joy SM; Sen S; Sen T
Indian J Pharmacol; 2017; 49(3):236-242. PubMed ID: 29033483
[TBL] [Abstract][Full Text] [Related]
3. Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Zhou C; Zhong J; Zou B; Fang L; Chen J; Deng X; Zhang L; Zhao X; Qu Z; Lei Y; Lei T
PLoS One; 2017; 12(2):e0172270. PubMed ID: 28241064
[TBL] [Abstract][Full Text] [Related]
4. Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression.
Yoshimura R; Ikenouchi-Sugita A; Hori H; Umene-Nakano W; Katsuki A; Hayashi K; Ueda N; Nakamura J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Mar; 34(2):308-12. PubMed ID: 20005280
[TBL] [Abstract][Full Text] [Related]
5. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological interventions for treatment-resistant depression in adults.
Davies P; Ijaz S; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD010557. PubMed ID: 31846068
[TBL] [Abstract][Full Text] [Related]
7. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants.
Shimizu E; Hashimoto K; Okamura N; Koike K; Komatsu N; Kumakiri C; Nakazato M; Watanabe H; Shinoda N; Okada S; Iyo M
Biol Psychiatry; 2003 Jul; 54(1):70-5. PubMed ID: 12842310
[TBL] [Abstract][Full Text] [Related]
8. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
Chiou YJ; Huang TL
World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
[TBL] [Abstract][Full Text] [Related]
9. Serum brain-derived neurotrophic factor, Val66Met polymorphism and open-label SSRI treatment response in Major Depressive Disorder.
Smit AJT; Wu GWY; Rampersaud R; Reus VI; Wolkowitz OM; Mellon SH
Psychoneuroendocrinology; 2024 Jul; 165():107045. PubMed ID: 38636352
[TBL] [Abstract][Full Text] [Related]
10. Low serum levels of brain-derived neurotrophic factor in patients with schizophrenia do not elevate after antipsychotic treatment.
Pirildar S; Gönül AS; Taneli F; Akdeniz F
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):709-13. PubMed ID: 15276697
[TBL] [Abstract][Full Text] [Related]
11. The role of BDNF in major depressive disorder, related clinical features, and antidepressant treatment: Insight from meta-analyses.
Cavaleri D; Moretti F; Bartoccetti A; Mauro S; Crocamo C; Carrà G; Bartoli F
Neurosci Biobehav Rev; 2023 Jun; 149():105159. PubMed ID: 37019247
[TBL] [Abstract][Full Text] [Related]
12. Changes of serum concentrations of brain-derived neurotrophic factor (BDNF) during treatment with venlafaxine and mirtazapine: role of medication and response to treatment.
Deuschle M; Gilles M; Scharnholz B; Lederbogen F; Lang UE; Hellweg R
Pharmacopsychiatry; 2013 Mar; 46(2):54-8. PubMed ID: 22961097
[TBL] [Abstract][Full Text] [Related]
13. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of nerve growth factor and brain-derived neurotrophic factor in depressed patients before and after antidepressant treatment.
Hellweg R; Ziegenhorn A; Heuser I; Deuschle M
Pharmacopsychiatry; 2008 Mar; 41(2):66-71. PubMed ID: 18311687
[TBL] [Abstract][Full Text] [Related]
15. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.
Fernandes BS; Steiner J; Berk M; Molendijk ML; Gonzalez-Pinto A; Turck CW; Nardin P; Gonçalves CA
Mol Psychiatry; 2015 Sep; 20(9):1108-19. PubMed ID: 25266124
[TBL] [Abstract][Full Text] [Related]
16. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
17. Investigating the potential role of BDNF and PRL genotypes on antidepressant response in depression patients: A prospective inception cohort study in treatment-free patients.
Ochi T; Vyalova NM; Losenkov IS; Levchuk LA; Osmanova DZ; Mikhalitskaya EV; Loonen AJM; Bosker FJ; Simutkin GG; Bokhan NA; Wilffert B; Ivanova SA
J Affect Disord; 2019 Dec; 259():432-439. PubMed ID: 31611000
[TBL] [Abstract][Full Text] [Related]
18. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants.
Huang TL; Lee CT; Liu YL
J Psychiatr Res; 2008 Jun; 42(7):521-5. PubMed ID: 17585940
[TBL] [Abstract][Full Text] [Related]
19. Brain-derived neurotrophic factor and initial antidepressant response to an N-methyl-D-aspartate antagonist.
Machado-Vieira R; Yuan P; Brutsche N; DiazGranados N; Luckenbaugh D; Manji HK; Zarate CA
J Clin Psychiatry; 2009 Dec; 70(12):1662-6. PubMed ID: 19744406
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological interventions for people with borderline personality disorder.
Stoffers-Winterling JM; Storebø OJ; Pereira Ribeiro J; Kongerslev MT; Völlm BA; Mattivi JT; Faltinsen E; Todorovac A; Jørgensen MS; Callesen HE; Sales CP; Schaug JP; Simonsen E; Lieb K
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD012956. PubMed ID: 36375174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
